Home
About Us
Company Profile
Enterprise culture
Qualification Honor
Chairman's Speech
News
Company Dynamics
Industry dynamics
Recruitment
Contact Us
Contact Information
Online message
Mar 28,2022
Epidemic prevention and control, we are in action
After the emergence of the "3.13" epidemic in Jinhua Jindong District, in order to do a good job in the prevention and control of the new coronary pneumonia epidemic, to ensure the health and safety of employees, Jianfeng Group and the subordinate enterprises in Jin actively deployed, the implementation of the prevention and control work.
Key words:
Peak Pharmaceutical Production Department Launches Theme Party Class
On March 18, the party branch of the production department of peak pharmaceutical organized party members to carry out thematic party classes, publicize and implement SASAC documents, and learn the basic knowledge of the party.
The pharmaceutical production department organizes female workers for an outing.
On March 12, Jianfeng Pharmaceutical Production Department organized all female workers to visit Jedao Mountain Scenic Area in Lingxia Town, jindong district.
Apr 11,2022
Opinions of the General Department of the State Food and Drug Administration on Strengthening the Collaborative Supervision of Cross-regional Commissioned Production of Medical Devices
The implementation of the medical device registrant system is an important measure to promote the reform of the medical device review and approval system and strengthen the management of the whole life cycle of medical devices. With the implementation of the regulations on the Supervision and Administration of Medical Devices (decree No. 739 of the State Council), the registrant system has been fully implemented, and the organizational forms of medical device production have become more diverse. in particular, medical device registrants carry out entrusted production across provinces, autonomous regions and municipalities directly under the Central Government (hereinafter referred to as "cross-regional entrusted production"), involving the division of responsibilities and coordination of provincial drug regulatory departments, bringing new challenges to the regulatory work. In order to effectively strengthen the supervision of cross-regional entrusted production by medical device registrants, consolidate the note.
Summary: Best time to take cardiovascular drugs
There are many kinds of cardiovascular diseases, and the corresponding treatment drugs are also numerous. When patients are faced with many drugs, it is easy to be puzzled by a question: when should this drug be taken? Today, we hereby summarize the best medication time for some cardiovascular drugs, hoping to be helpful to everyone.
The General Department of the State Food and Drug Administration publicly solicits opinions on the "Pharmaceutical Business Quality Management Practice-Drug Retail Distribution Quality Management Appendix (Draft for Solicitation of Comments)"
In order to further standardize the behavior of drug retail distribution and ensure the quality and safety of drugs in retail distribution, the State Food and Drug Administration has organized the drafting of the "Pharmaceutical Business quality Management Standard-Drug Retail Distribution quality Management Appendix (draft for soliciting opinions)" (Annex 1). Please fill in the feedback form (Annex 2) and send it back to the e-mail box before March 31, 2022: ypjgs@nmpa.gov.cn. Please indicate "Feedback on Appendix to Drug Retail Distribution Quality Management" in the subject of the e-mail ".